Related Experiment Video
Updated: Jul 27, 2026
08:16
Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
Published on: June 17, 2015
Androgens modulate beta-amyloid levels in male rat brain
M Ramsden1, A C Nyborg, M P Murphy
1Andrus Gerontology Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089-0191, USA.
Journal of Neurochemistry
|November 19, 2003
Summary
Aging men experience declining androgen levels, potentially increasing Alzheimer's disease (AD) risk. This study shows androgens regulate beta-amyloid (Abeta) levels, suggesting a link between low androgens and AD development.
Area of Science:
- Neuroendocrinology
- Neurodegenerative Diseases
Background:
- Aging is associated with declining androgen levels in men.
- The neural impact of age-related androgen depletion is not fully understood.
- Emerging evidence links low androgens to Alzheimer's disease (AD) development.
Purpose of the Study:
- To investigate the hypothesis that androgens modulate beta-amyloid protein (Abeta) levels.
- To explore the role of androgens in the accumulation of Abeta in the brain.
Main Methods:
- Measuring brain and plasma Abeta levels in male rats under different hormonal conditions.
- Utilizing gonadectomy (GDX) to deplete endogenous sex steroid hormones.
- Administering dihydrotestosterone (DHT) supplementation to assess its effect on Abeta levels.
Main Results:
- Gonadectomy (GDX) led to increased brain Abeta levels compared to intact male rats.
- DHT supplementation reversed the GDX-induced increase in Abeta levels.
- This demonstrates a functional role for androgens in regulating brain Abeta.
Conclusions:
- Androgens play a role in modulating brain Abeta levels.
- Age-related androgen depletion may contribute to Abeta accumulation in the male brain.
- This accumulation could represent a risk factor for Alzheimer's disease development.
